Immunotherapies Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
ELTX | D | Elicio Therapeutics, Inc. | 5.07 | |
PYXS | D | Pyxis Oncology, Inc. | 9.66 | |
SLS | D | SELLAS Life Sciences Group, Inc. | -2.83 | |
XLO | D | Xilio Therapeutics, Inc. | -3.08 | |
IMCR | D | Immunocore Holdings plc | 3.11 | |
RCUS | D | Arcus Biosciences, Inc. | 9.37 | |
MURA | D | Mural Oncology plc | 10.24 | |
ADAG | D | Adagene Inc. | 1.59 | |
AFMD | F | Affimed Therapeutics B.V. | 0.19 | |
GDTC | F | CytoMed Therapeutics Limited | 7.18 |
Related Industries: Biotechnology Long-Term Care Facilities Medical Devices
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
SBIO | C | ALPS Medical Breakthroughs ETF | 2.58 | |
BBC | C | Virtus LifeSci Biotech Clinical Trials ETF | 2.35 | |
XBI | C | SPDR S&P Biotech ETF | 1.73 | |
PTH | C | Invesco DWA Healthcare Momentum ETF | 1.6 | |
LABU | D | Direxion Daily S&P Biotech Bull 3X Shares | 1.15 |
Compare ETFs
- Immunotherapies
Immunotherapy is the treatment of disease by activating or suppressing the immune system. Immunotherapies designed to elicit or amplify an immune response are classified as activation immunotherapies, while immunotherapies that reduce or suppress are classified as suppression immunotherapies.
In recent years, immunotherapy has become of great interest to researchers, clinicians and pharmaceutical companies, particularly in its promise to treat various forms of cancer.Immunomodulatory regimens often have fewer side effects than existing drugs, including less potential for creating resistance when treating microbial disease.Cell-based immunotherapies are effective for some cancers. Immune effector cells such as lymphocytes, macrophages, dendritic cells, natural killer cells (NK Cell), cytotoxic T lymphocytes (CTL), etc., work together to defend the body against cancer by targeting abnormal antigens expressed on the surface of tumor cells.
Therapies such as granulocyte colony-stimulating factor (G-CSF), interferons, imiquimod and cellular membrane fractions from bacteria are licensed for medical use. Others including IL-2, IL-7, IL-12, various chemokines, synthetic cytosine phosphate-guanosine (CpG) oligodeoxynucleotides and glucans are involved in clinical and preclinical studies.
Popular Now
Recent Comments
- TraderMike on Market Recap for Friday, March 8, 2024
- Don_Marat on Market Recap for Friday, March 8, 2024
- TraderMike on Trades of the Week: Feb 12 - Feb 16, 2024
- Cos3 on Trades of the Week: Feb 12 - Feb 16, 2024
- SwingTradeBot on Market Recap for Tuesday, February 27, 2024
From the Blog
Featured Articles